{"transactions":[{"id":4627879,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Performance Stock Units","published_at":"2026-09-28T23:05:55.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The award was granted at a target level of 155,000 PSUs. The number of PSUs that may be earned depends on achievement of specified stock-price hurdles during the performance period beginning September 1, 2026 and ending September 1, 2031. Achievement is measured using the\naverage closing price of the Issuer's common stock over any consecutive 60-trading-day period. Potential payouts are 0%, 50%, 100%, 150% or 200% of the target number of PSUs, subject to the award's interpolation provisions. The\napplicable hurdles are $17.00, $22.00, $27.00 and $32.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"PSUs earned with respect to an achieved hurdle vest one-third upon certification of achievement, one-third on the first anniversary of certification and one-third on the second anniversary, generally subject to continued service. Any\noutstanding earned PSUs vest no later than September 1, 2031. Earned and vested PSUs are settled in shares following vesting, subject to the deferred settlement provisions of the award. The actual number earned may range from zero\nto 200% of the target award. PSUs that are not earned by the end of the performance period are forfeited. Dividend equivalents accrue on the PSUs and are subject to the same earning and vesting conditions. Vested dividend\nequivalents are settled in shares when the related PSUs are settled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"PSUs earned with respect to an achieved hurdle vest one-third upon certification of achievement, one-third on the first anniversary of certification and one-third on the second anniversary, generally subject to continued service. Any\noutstanding earned PSUs vest no later than September 1, 2031. Earned and vested PSUs are settled in shares following vesting, subject to the deferred settlement provisions of the award. The actual number earned may range from zero\nto 200% of the target award. PSUs that are not earned by the end of the performance period are forfeited. Dividend equivalents accrue on the PSUs and are subject to the same earning and vesting conditions. Vested dividend\nequivalents are settled in shares when the related PSUs are settled."}],"balance_after":155000,"derivative":{"exercise_price":0,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001412408-26-000252","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000252/form4.xml","form_type":"4"}},{"id":4624666,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-09-22T20:27:34.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":319,"price":10.42,"value":3323.98,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units and does not represent a sale by the Reporting Person's spouse."}],"balance_after":22267,"source":{"system":"sec-edgar","filing":"0001412408-26-000244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000244/form4.xml","form_type":"4"}},{"id":4624665,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-09-22T20:27:34.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":4475,"price":10.42,"value":46629.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":419694,"source":{"system":"sec-edgar","filing":"0001412408-26-000244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000244/form4.xml","form_type":"4"}},{"id":4619400,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-09-16T20:29:45.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":703,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 25% of the Reporting Person's spouse's cash bonus earned for the first half of the fiscal year ending January 31, 2027 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person's spouse elected to convert such cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $10.42, the closing price of the Issuer's common stock on September 14, 2026."}],"balance_after":22586,"source":{"system":"sec-edgar","filing":"0001412408-26-000237","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000237/form4.xml","form_type":"4"}},{"id":4619399,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-09-16T20:29:45.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":8113,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2027 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $10.42, the closing price of the Issuer's common stock on September 14, 2026."}],"balance_after":424169,"source":{"system":"sec-edgar","filing":"0001412408-26-000237","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000237/form4.xml","form_type":"4"}},{"id":3957,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-09-04T00:40:03.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares reported in this transaction represent RSUs issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in five substantially equal annual installments beginning on September 1, 2027, subject to the Reporting Person's spouse's continued service to the Issuer through each vesting date."}],"balance_after":21883,"source":{"system":"sec-edgar","filing":"0001412408-26-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000230/form4.xml","form_type":"4"}},{"id":3956,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-09-04T00:40:03.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":192000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in five substantially equal annual installments beginning on September 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":416056,"source":{"system":"sec-edgar","filing":"0001412408-26-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000230/form4.xml","form_type":"4"}},{"id":685577,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-08-17T21:57:33.000Z","date":"2026-08-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":182,"price":12.28,"value":2234.96,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of Restricted Stock Units and does not represent a sale by the Reporting Person or his spouse."}],"balance_after":11883,"source":{"system":"sec-edgar","filing":"0001412408-26-000205","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000205/form4.xml","form_type":"4"}},{"id":706911,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-07-17T20:10:52.000Z","date":"2026-07-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":69,"price":10.76,"value":742.44,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units and does not represent a sale by the Reporting Person or his spouse."}],"balance_after":12065,"source":{"system":"sec-edgar","filing":"0001412408-26-000199","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000199/form4.xml","form_type":"4"}},{"id":804521,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-04-20T20:28:43.000Z","date":"2026-04-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":229,"price":9.17,"value":2099.93,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":12134,"source":{"system":"sec-edgar","filing":"0001412408-26-000128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000128/form4.xml","form_type":"4"}},{"id":809687,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-04-14T00:01:05.000Z","date":"2026-04-10","kind":"sale","planned":true,"acquired":false,"shares":8332,"price":8.07,"value":67239.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 15, 2025."}],"balance_after":224056,"source":{"system":"sec-edgar","filing":"0001412408-26-000112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000112/form4.xml","form_type":"4"}},{"id":809686,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-04-14T00:01:05.000Z","date":"2026-04-09","kind":"tax_withholding","planned":true,"acquired":false,"shares":914,"price":9.15,"value":8363.1,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":12363,"source":{"system":"sec-edgar","filing":"0001412408-26-000112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000112/form4.xml","form_type":"4"}},{"id":809685,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-04-14T00:01:05.000Z","date":"2026-04-09","kind":"tax_withholding","planned":true,"acquired":false,"shares":9454,"price":9.15,"value":86504.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":232388,"source":{"system":"sec-edgar","filing":"0001412408-26-000112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000112/form4.xml","form_type":"4"}},{"id":812581,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-04-08T21:30:21.000Z","date":"2026-04-06","kind":"grant","planned":false,"acquired":true,"shares":2209,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's spouse's cash bonus earned for the fiscal year ending January 31, 2026 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person's spouse elected to convert such cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $9.15, the closing price of the Issuer's common stock on April 6, 2026."}],"balance_after":13277,"source":{"system":"sec-edgar","filing":"0001412408-26-000101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000101/form4.xml","form_type":"4"}},{"id":812580,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-04-08T21:30:21.000Z","date":"2026-04-06","kind":"grant","planned":false,"acquired":true,"shares":17786,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ending January 31, 2026 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $9.15, the closing price of the Issuer's common stock on April 6, 2026."}],"balance_after":241842,"source":{"system":"sec-edgar","filing":"0001412408-26-000101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000101/form4.xml","form_type":"4"}},{"id":833552,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-03-19T20:17:03.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":107,"price":11.0591,"value":1183.3237,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.91 to $11.16 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11068,"source":{"system":"sec-edgar","filing":"0001412408-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000059/form4.xml","form_type":"4"}},{"id":901156,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-02-17T21:47:17.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":26.73,"value":40095.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued to the Reporting Person's spouse under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on July 15, 2026, 20% of the RSUs shall vest on July 15, 2027, 30% of the RSUs shall vest on July 15, 2028 and 40% of the RSUs shall vest on July 15, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total in Column 5 has been adjusted to correct an understatement of direct holdings by 114 shares and an overstatement of indirect holdings by 114 shares, first reflected in a Form 4 filed September 18, 2025. A sale of 114 shares by the Reporting Person's spouse on September 16, 2025 was timely reported but inadvertently reported the form of ownership as direct rather than indirect."}],"balance_after":11175,"source":{"system":"sec-edgar","filing":"0001412408-26-000050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000050/form4.xml","form_type":"4"}},{"id":935431,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-01-20T22:10:20.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":6038,"price":16.3568,"value":98762.3584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.14 to $16.495 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":223942,"source":{"system":"sec-edgar","filing":"0001412408-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000030/form4.xml","form_type":"4"}},{"id":935430,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-01-20T22:10:20.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":1743,"price":16.3795,"value":28549.4685,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.185 to $16.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":229980,"source":{"system":"sec-edgar","filing":"0001412408-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000030/form4.xml","form_type":"4"}},{"id":941079,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2026-01-12T22:01:50.000Z","date":"2026-01-08","kind":"sale","planned":false,"acquired":false,"shares":6106,"price":17.0071,"value":103845.3526,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.81 to $17.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":231723,"source":{"system":"sec-edgar","filing":"0001412408-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240826000016/form4.xml","form_type":"4"}},{"id":962067,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-12-19T22:27:13.000Z","date":"2025-12-17","kind":"sale","planned":false,"acquired":false,"shares":94,"price":16.4863,"value":1549.7122,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.26 to $16.59 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9789,"source":{"system":"sec-edgar","filing":"0001412408-25-000144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000144/form4.xml","form_type":"4"}},{"id":976237,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-12-09T22:46:46.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on December 5, 2026, 20% of the RSUs shall vest on December 5, 2027, 30% of the RSUs shall vest on December 5, 2028 and 40% of the RSUs shall vest on December 5, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. The grant of RSUs was approved by the Compensation Committee of the Board of Directors on October 1, 2025."}],"balance_after":237829,"source":{"system":"sec-edgar","filing":"0001412408-25-000135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000135/form4.xml","form_type":"4"}},{"id":1015274,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-10-21T20:50:46.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":2059,"price":22.3612,"value":46041.7108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.195 to $22.66 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":171829,"source":{"system":"sec-edgar","filing":"0001412408-25-000094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000094/form4.xml","form_type":"4"}},{"id":1034608,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-09-22T20:15:25.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":93,"price":23.9387,"value":2226.2991,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.455 to $24.205 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9883,"source":{"system":"sec-edgar","filing":"0001412408-25-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000086/form4.xml","form_type":"4"}},{"id":1036378,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-09-18T21:38:18.000Z","date":"2025-09-17","kind":"sale","planned":true,"acquired":false,"shares":1064,"price":23.5,"value":25004.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 15, 2025."}],"balance_after":173888,"source":{"system":"sec-edgar","filing":"0001412408-25-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000079/form4.xml","form_type":"4"}},{"id":1036377,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-09-18T21:38:18.000Z","date":"2025-09-16","kind":"sale","planned":true,"acquired":false,"shares":114,"price":23.2844,"value":2654.4216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.83 to $23.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":174952,"source":{"system":"sec-edgar","filing":"0001412408-25-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000079/form4.xml","form_type":"4"}},{"id":1036376,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-09-18T21:38:18.000Z","date":"2025-09-16","kind":"sale","planned":true,"acquired":false,"shares":2051,"price":23.2844,"value":47756.3044,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.83 to $23.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":175066,"source":{"system":"sec-edgar","filing":"0001412408-25-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000079/form4.xml","form_type":"4"}},{"id":1040565,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-09-15T20:34:29.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":259,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's spouse's cash bonus earned for the fiscal first half of the year ending January 31, 2026 under the Issuer's Variable Compensation Plan. The Reporting Person's spouse elected to convert such portion of their earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted is based on a per share value of $25.48, the closing price of the Issuer's common stock on September 11, 2025."}],"balance_after":9976,"source":{"system":"sec-edgar","filing":"0001412408-25-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000070/form4.xml","form_type":"4"}},{"id":1040564,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-09-15T20:34:29.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":3115,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1. Represents Restricted Stock Units (\"RSUs\") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2026 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of their cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $25.48, the closing price of the Issuer's common stock on September 11, 2025."}],"balance_after":177117,"source":{"system":"sec-edgar","filing":"0001412408-25-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000070/form4.xml","form_type":"4"}},{"id":1055767,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-08-26T20:46:44.000Z","date":"2025-08-22","kind":"sale","planned":true,"acquired":false,"shares":17445,"price":29.7324,"value":518681.718,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.64 to $29.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":174002,"source":{"system":"sec-edgar","filing":"0001127602-25-020954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225020954/form4.xml","form_type":"4"}},{"id":1060357,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"President, Network Solutions"}}],"security":"Common Stock","published_at":"2025-08-20T20:37:08.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":78,"price":29.1555,"value":2274.129,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.77 to $29.40 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9717,"source":{"system":"sec-edgar","filing":"0001127602-25-020785","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225020785/form4.xml","form_type":"4"}},{"id":1084064,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Network Solutions"}}],"security":"Common Stock","published_at":"2025-07-21T20:18:26.000Z","date":"2025-07-17","kind":"sale","planned":false,"acquired":false,"shares":2063,"price":26.8858,"value":55465.4054,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.38 to $27.29 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":191447,"source":{"system":"sec-edgar","filing":"0001127602-25-019456","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225019456/form4.xml","form_type":"4"}},{"id":1097960,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Network Solutions"}}],"security":"Common Stock","published_at":"2025-07-02T01:41:03.000Z","date":"2025-06-27","kind":"sale","planned":true,"acquired":false,"shares":23729,"price":28.4966,"value":676195.8214,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.42 to $28.765 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":193510,"source":{"system":"sec-edgar","filing":"0001127602-25-018423","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225018423/form4.xml","form_type":"4"}},{"id":1105065,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Network Solutions"}}],"security":"Common Stock","published_at":"2025-06-20T20:49:13.000Z","date":"2025-06-18","kind":"sale","planned":false,"acquired":false,"shares":67,"price":25.6114,"value":1715.9638,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.255 to $25.935 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9795,"source":{"system":"sec-edgar","filing":"0001412408-25-000044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000044/form4.xml","form_type":"4"}},{"id":1105064,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Network Solutions"}}],"security":"Common Stock","published_at":"2025-06-20T20:49:13.000Z","date":"2025-06-17","kind":"sale","planned":false,"acquired":false,"shares":42,"price":25.1721,"value":1057.2282,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.68 to $25.675 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9862,"source":{"system":"sec-edgar","filing":"0001412408-25-000044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000141240825000044/form4.xml","form_type":"4"}},{"id":1153811,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-05-09T20:24:06.000Z","date":"2023-12-18","kind":"sale","planned":false,"acquired":false,"shares":100,"price":23.1527,"value":2315.27,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of RSUs. The transaction was originally reported in a Form 4 filed on December 20, 2023 that contained an error in the number of shares in Column 4. The transaction is being re-reported in order to correct the number of shares in Column 4. Forms 4 filed after the transaction date understated the total common stock holdings of the Reporting Person's spouse by 134 shares."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.96 to $23.33 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total in Column 5 has been adjusted to correct (i) an overstatement of holdings by 116 shares first reflected in a Form 4 filed on September 14, 2022 and (ii) an overstatement of holdings by 236 shares first reflected in a Form 4 filed on April 12, 2023."}],"balance_after":9904,"source":{"system":"sec-edgar","filing":"0001127602-25-013853","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225013853/form4.xml","form_type":"4"}},{"id":1153810,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-05-09T20:24:06.000Z","date":"2022-12-15","kind":"sale","planned":false,"acquired":false,"shares":22,"price":34.01,"value":748.22,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person or his spouse. The transaction was not previously reported due to administrative oversight. Forms 4 filed after the transaction date overstated the total common stock holdings of the Reporting Person's spouse by 22 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total in Column 5 has been adjusted to correct (i) an overstatement of holdings by 116 shares first reflected in a Form 4 filed on September 14, 2022 and (ii) an overstatement of holdings by 236 shares first reflected in a Form 4 filed on April 12, 2023."}],"balance_after":9770,"source":{"system":"sec-edgar","filing":"0001127602-25-013853","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225013853/form4.xml","form_type":"4"}},{"id":1153809,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-05-09T20:24:06.000Z","date":"2022-09-15","kind":"grant","planned":false,"acquired":true,"shares":1392,"price":28.72,"value":39978.24,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") issued to the Reporting Person's spouse under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest 6.25% on each quarterly vesting date over four years, beginning on December 15, 2022. The transaction was not previously reported due to administrative oversight. Forms 4 filed after the transaction date understated the total common stock holdings of the Reporting Person's spouse by 1,392 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total in Column 5 has been adjusted to correct (i) an overstatement of holdings by 116 shares first reflected in a Form 4 filed on September 14, 2022 and (ii) an overstatement of holdings by 236 shares first reflected in a Form 4 filed on April 12, 2023."}],"balance_after":9792,"source":{"system":"sec-edgar","filing":"0001127602-25-013853","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225013853/form4.xml","form_type":"4"}},{"id":1167113,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-04-23T20:24:34.000Z","date":"2025-04-21","kind":"sale","planned":false,"acquired":false,"shares":260,"price":23.0418,"value":5990.868,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.75 to $23.675 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8752,"source":{"system":"sec-edgar","filing":"0001127602-25-012493","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225012493/form4.xml","form_type":"4"}},{"id":1169863,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-04-17T21:05:42.000Z","date":"2025-04-16","kind":"sale","planned":true,"acquired":false,"shares":2488,"price":23.66,"value":58866.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 15, 2025."}],"balance_after":217239,"source":{"system":"sec-edgar","filing":"0001127602-25-012308","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225012308/form4.xml","form_type":"4"}},{"id":1169862,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-04-17T21:05:42.000Z","date":"2025-04-16","kind":"sale","planned":true,"acquired":false,"shares":2011,"price":23.8072,"value":47876.2792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.39 to $24.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":219727,"source":{"system":"sec-edgar","filing":"0001127602-25-012308","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225012308/form4.xml","form_type":"4"}},{"id":1174114,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-04-11T00:59:53.000Z","date":"2025-04-08","kind":"sale","planned":false,"acquired":false,"shares":96,"price":24.475,"value":2349.6,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9012,"source":{"system":"sec-edgar","filing":"0001127602-25-011940","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225011940/form4.xml","form_type":"4"}},{"id":1174113,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-04-11T00:59:53.000Z","date":"2025-04-08","kind":"sale","planned":false,"acquired":false,"shares":152,"price":23.4568,"value":3565.4336,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9108,"source":{"system":"sec-edgar","filing":"0001127602-25-011940","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225011940/form4.xml","form_type":"4"}},{"id":1174112,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-04-11T00:59:53.000Z","date":"2025-04-08","kind":"sale","planned":false,"acquired":false,"shares":1534,"price":24.475,"value":37544.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":221738,"source":{"system":"sec-edgar","filing":"0001127602-25-011940","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225011940/form4.xml","form_type":"4"}},{"id":1174111,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-04-11T00:59:53.000Z","date":"2025-04-08","kind":"sale","planned":false,"acquired":false,"shares":2410,"price":23.4568,"value":56530.888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":223272,"source":{"system":"sec-edgar","filing":"0001127602-25-011940","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225011940/form4.xml","form_type":"4"}},{"id":1175663,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-08T23:06:41.000Z","date":"2020-02-21","kind":"exercise","planned":false,"acquired":false,"shares":3413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an option exercise that was not previously reported due to a vendor administrative oversight. Forms 4 filed after the date of exercise underreported total common stock holdings by 3,413 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested and exercisable as of the date of the reported transaction."}],"balance_after":0,"derivative":{"exercise_price":0.73,"expiration_date":"2020-02-25","underlying":"Common Stock","underlying_shares":3413},"source":{"system":"sec-edgar","filing":"0001127602-25-011830","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225011830/form4.xml","form_type":"4"}},{"id":1175662,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-04-08T23:06:41.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":536,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ending January 31, 2025 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $24.31, the closing price of the Issuer's common stock on April 4, 2025."}],"balance_after":9260,"source":{"system":"sec-edgar","filing":"0001127602-25-011830","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225011830/form4.xml","form_type":"4"}},{"id":1175661,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-04-08T23:06:41.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":6432,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ending January 31, 2025 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $24.31, the closing price of the Issuer's common stock on April 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total in Column 5 has been adjusted to correct an overstatement of holdings by 2,298 shares first reflected in a Form 4 filed on May 5, 2021."}],"balance_after":225682,"source":{"system":"sec-edgar","filing":"0001127602-25-011830","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225011830/form4.xml","form_type":"4"}},{"id":1175660,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-04-08T23:06:41.000Z","date":"2020-02-21","kind":"exercise","planned":false,"acquired":true,"shares":3413,"price":0.73,"value":2491.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an option exercise that was not previously reported due to a vendor administrative oversight. Forms 4 filed after the date of exercise underreported total common stock holdings by 3,413 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total in Column 5 has been adjusted to correct an overstatement of holdings by 2,298 shares first reflected in a Form 4 filed on May 5, 2021."}],"balance_after":219250,"source":{"system":"sec-edgar","filing":"0001127602-25-011830","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225011830/form4.xml","form_type":"4"}},{"id":1195764,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-03-20T21:01:48.000Z","date":"2025-03-19","kind":"sale","planned":false,"acquired":false,"shares":7,"price":28.3112,"value":198.1784,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.21 to $28.465 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8724,"source":{"system":"sec-edgar","filing":"0001127602-25-010163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225010163/form4.xml","form_type":"4"}},{"id":1195763,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-03-20T21:01:48.000Z","date":"2025-03-19","kind":"sale","planned":false,"acquired":false,"shares":81,"price":27.8479,"value":2255.6799,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.21 to $28.205 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8731,"source":{"system":"sec-edgar","filing":"0001127602-25-010163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225010163/form4.xml","form_type":"4"}},{"id":1195762,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-03-20T21:01:48.000Z","date":"2025-03-18","kind":"sale","planned":false,"acquired":false,"shares":39,"price":26.9507,"value":1051.0773,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.51 to $27.215 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8812,"source":{"system":"sec-edgar","filing":"0001127602-25-010163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225010163/form4.xml","form_type":"4"}},{"id":1263896,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-02-18T21:35:06.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":11616,"price":29.7005,"value":345001.008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":218135,"source":{"system":"sec-edgar","filing":"0001127602-25-005239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225005239/form4.xml","form_type":"4"}},{"id":1274083,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-02-11T23:16:32.000Z","date":"2025-02-07","kind":"sale","planned":true,"acquired":false,"shares":300,"price":29.5233,"value":8856.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.55 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":229751,"source":{"system":"sec-edgar","filing":"0001127602-25-004226","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225004226/form4.xml","form_type":"4"}},{"id":1278816,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-02-07T21:51:50.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":720,"price":29.5013,"value":21240.936,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.52 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":230051,"source":{"system":"sec-edgar","filing":"0001127602-25-003595","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225003595/form4.xml","form_type":"4"}},{"id":1289599,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-01-31T21:23:49.000Z","date":"2025-01-29","kind":"sale","planned":true,"acquired":false,"shares":500,"price":29.682,"value":14841.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.595 to $29.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":230771,"source":{"system":"sec-edgar","filing":"0001127602-25-002618","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225002618/form4.xml","form_type":"4"}},{"id":1291907,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-01-29T21:47:58.000Z","date":"2025-01-27","kind":"sale","planned":false,"acquired":false,"shares":3527,"price":28.1505,"value":99286.8135,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of performance-based restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.75 to $28.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":231271,"source":{"system":"sec-edgar","filing":"0001127602-25-002282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225002282/form4.xml","form_type":"4"}},{"id":1291906,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-01-29T21:47:58.000Z","date":"2025-01-27","kind":"sale","planned":false,"acquired":false,"shares":8158,"price":27.1848,"value":221773.5984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of performance-based restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.75 to $27.74 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":234798,"source":{"system":"sec-edgar","filing":"0001127602-25-002282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225002282/form4.xml","form_type":"4"}},{"id":1295646,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-01-25T00:51:25.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":19564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent common stock awarded due to the vesting of performance-based restricted stock units (\"PSUs\") for which the performance period ended on January 14, 2025. On January 23, 2025, the Compensation Committee determined and certified the number of shares of common stock earned by the Reporting Person based upon the Issuer's achievement of pre-established performance criteria. The PSUs were awarded under the Issuer's 2019 Stock Option and Incentive Plan."}],"balance_after":242956,"source":{"system":"sec-edgar","filing":"0001127602-25-001983","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225001983/form4.xml","form_type":"4"}},{"id":1297745,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-01-22T21:59:34.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":13873,"price":27.3107,"value":378881.3411,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.025 to $27.66 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":223392,"source":{"system":"sec-edgar","filing":"0001127602-25-001745","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225001745/form4.xml","form_type":"4"}},{"id":1300182,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-01-17T23:03:53.000Z","date":"2025-01-15","kind":"sale","planned":false,"acquired":false,"shares":1946,"price":26.9813,"value":52505.6098,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.6905 to $27.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":237265,"source":{"system":"sec-edgar","filing":"0001127602-25-001468","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225001468/form4.xml","form_type":"4"}},{"id":1306737,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-01-08T22:21:04.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":3133,"price":26.6055,"value":83355.0315,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.26 to $26.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":239211,"source":{"system":"sec-edgar","filing":"0001127602-25-001026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225001026/form4.xml","form_type":"4"}},{"id":1310838,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2025-01-07T01:06:41.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":53990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on January 2, 2026, 20% of the RSUs shall vest on January 2, 2027, 30% of the RSUs shall vest on January 2, 2028 and 40% of the RSUs shall vest on January 2, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":242344,"source":{"system":"sec-edgar","filing":"0001127602-25-000862","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760225000862/form4.xml","form_type":"4"}},{"id":1325468,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-12-19T22:59:45.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":24,"price":25.376,"value":609.024,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.86 to $25.58 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8851,"source":{"system":"sec-edgar","filing":"0001127602-24-029816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224029816/form4.xml","form_type":"4"}},{"id":1326803,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-12-19T01:30:38.000Z","date":"2024-12-17","kind":"sale","planned":false,"acquired":false,"shares":2,"price":25.7663,"value":51.5326,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.665 to $25.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8875,"source":{"system":"sec-edgar","filing":"0001127602-24-029756","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224029756/form4.xml","form_type":"4"}},{"id":1326802,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-12-19T01:30:38.000Z","date":"2024-12-17","kind":"sale","planned":false,"acquired":false,"shares":59,"price":25.0385,"value":1477.2715,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.60 to $25.55 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8877,"source":{"system":"sec-edgar","filing":"0001127602-24-029756","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224029756/form4.xml","form_type":"4"}},{"id":1326801,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-12-19T01:30:38.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":35,"price":24.8825,"value":870.8875,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.415 to $25.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8936,"source":{"system":"sec-edgar","filing":"0001127602-24-029756","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224029756/form4.xml","form_type":"4"}},{"id":1332441,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-12-13T21:13:22.000Z","date":"2024-12-11","kind":"sale","planned":true,"acquired":false,"shares":11853,"price":24.851,"value":294558.903,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.50 to $25.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":188354,"source":{"system":"sec-edgar","filing":"0001127602-24-029339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224029339/form4.xml","form_type":"4"}},{"id":1382995,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-10-22T21:51:02.000Z","date":"2024-10-18","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":20.49,"value":22539.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on July 18, 2024."}],"balance_after":200207,"source":{"system":"sec-edgar","filing":"0001127602-24-025865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224025865/form4.xml","form_type":"4"}},{"id":1384866,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-10-17T20:31:46.000Z","date":"2024-10-15","kind":"sale","planned":false,"acquired":false,"shares":2011,"price":21.0251,"value":42281.4761,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.755 to $21.34 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":201307,"source":{"system":"sec-edgar","filing":"0001127602-24-025708","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224025708/form4.xml","form_type":"4"}},{"id":1401660,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-09-20T20:39:24.000Z","date":"2024-09-19","kind":"sale","planned":false,"acquired":false,"shares":24,"price":24.0433,"value":577.0392,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."}],"balance_after":8971,"source":{"system":"sec-edgar","filing":"0001127602-24-024288","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224024288/form4.xml","form_type":"4"}},{"id":1402456,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-09-19T21:49:33.000Z","date":"2024-09-18","kind":"sale","planned":false,"acquired":false,"shares":61,"price":24.0866,"value":1469.2826,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of RSUs."}],"balance_after":8995,"source":{"system":"sec-edgar","filing":"0001127602-24-024260","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224024260/form4.xml","form_type":"4"}},{"id":1402455,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-09-19T21:49:33.000Z","date":"2024-09-17","kind":"sale","planned":false,"acquired":false,"shares":36,"price":24.7651,"value":891.5436,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of RSUs."}],"balance_after":9056,"source":{"system":"sec-edgar","filing":"0001127602-24-024260","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224024260/form4.xml","form_type":"4"}},{"id":1408709,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-09-12T21:58:19.000Z","date":"2024-09-10","kind":"sale","planned":false,"acquired":false,"shares":95,"price":23.2502,"value":2208.769,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.94 to $23.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9092,"source":{"system":"sec-edgar","filing":"0001127602-24-023869","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224023869/form4.xml","form_type":"4"}},{"id":1408708,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-09-12T21:58:19.000Z","date":"2024-09-10","kind":"sale","planned":false,"acquired":false,"shares":1716,"price":23.2502,"value":39897.3432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.94 to $23.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":203318,"source":{"system":"sec-edgar","filing":"0001127602-24-023869","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224023869/form4.xml","form_type":"4"}},{"id":1410861,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-09-10T20:56:06.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":234,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's spouse's cash bonus earned for the fiscal first half of the year ending January 31, 2025 under the Issuer's Variable Compensation Plan. The Reporting Person's spouse elected to convert such portion of her earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted is based on a per share value of $23.55, the closing price of the Issuer's common stock on September 6, 2024."}],"balance_after":9187,"source":{"system":"sec-edgar","filing":"0001127602-24-023716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224023716/form4.xml","form_type":"4"}},{"id":1410860,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-09-10T20:56:06.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":2816,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2025 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $23.55, the closing price of the Issuer's common stock on September 6, 2024."}],"balance_after":205034,"source":{"system":"sec-edgar","filing":"0001127602-24-023716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224023716/form4.xml","form_type":"4"}},{"id":1431418,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-08-16T20:05:31.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on August 15, 2025, 20% of the RSUs shall vest on August 15, 2026, 30% of the RSUs shall vest on August 15, 2027 and 40% of the RSUs shall vest on August 15, 2028, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":8953,"source":{"system":"sec-edgar","filing":"0001127602-24-022356","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224022356/form4.xml","form_type":"4"}},{"id":1452649,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-07-17T21:31:32.000Z","date":"2024-07-16","kind":"sale","planned":false,"acquired":false,"shares":1820,"price":23.7356,"value":43198.792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units."}],"balance_after":202218,"source":{"system":"sec-edgar","filing":"0001127602-24-020618","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224020618/form4.xml","form_type":"4"}},{"id":1470736,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-06-24T20:29:34.000Z","date":"2024-06-21","kind":"sale","planned":false,"acquired":false,"shares":27,"price":20.2365,"value":546.3855,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."}],"balance_after":6953,"source":{"system":"sec-edgar","filing":"0001127602-24-019155","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224019155/form4.xml","form_type":"4"}},{"id":1472139,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-06-21T20:35:56.000Z","date":"2024-06-20","kind":"sale","planned":false,"acquired":false,"shares":66,"price":19.7322,"value":1302.3252,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of RSUs."}],"balance_after":6980,"source":{"system":"sec-edgar","filing":"0001127602-24-019127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224019127/form4.xml","form_type":"4"}},{"id":1472138,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"officer":true,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-06-21T20:35:56.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":41,"price":19.1971,"value":787.0811,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of RSUs."}],"balance_after":7046,"source":{"system":"sec-edgar","filing":"0001127602-24-019127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000112760224019127/form4.xml","form_type":"4"}},{"id":1538447,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-04-19T20:24:16.000Z","date":"2024-04-18","kind":"sale","planned":false,"acquired":false,"shares":269,"price":22.847,"value":6145.843,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.56 to $23.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7087,"source":{"system":"sec-edgar","filing":"0001562180-24-003481","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024003481/primarydocument.xml","form_type":"4"}},{"id":1540039,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-04-17T20:13:22.000Z","date":"2024-04-15","kind":"sale","planned":false,"acquired":false,"shares":2212,"price":22.8574,"value":50560.5688,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.63 to $23.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":204038,"source":{"system":"sec-edgar","filing":"0001562180-24-003446","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024003446/primarydocument.xml","form_type":"4"}},{"id":1543840,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-04-10T21:18:39.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":2,"price":23.0163,"value":46.0326,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.04 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7356,"source":{"system":"sec-edgar","filing":"0001562180-24-003385","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024003385/primarydocument.xml","form_type":"4"}},{"id":1543839,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-04-10T21:18:39.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":245,"price":22.6161,"value":5540.9445,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7358,"source":{"system":"sec-edgar","filing":"0001562180-24-003385","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024003385/primarydocument.xml","form_type":"4"}},{"id":1543838,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-04-10T21:18:39.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":39,"price":23.0163,"value":897.6357,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.04 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":206250,"source":{"system":"sec-edgar","filing":"0001562180-24-003385","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024003385/primarydocument.xml","form_type":"4"}},{"id":1543837,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-04-10T21:18:39.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":3875,"price":22.6161,"value":87637.3875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":206289,"source":{"system":"sec-edgar","filing":"0001562180-24-003385","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024003385/primarydocument.xml","form_type":"4"}},{"id":1544589,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-04-09T23:37:36.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":508,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's spouse's cash bonus earned for the fiscal year ended January 31, 2024 under the Issuer's Variable Compensation Plan. The Reporting Person's spouse elected to convert such portion of her earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted are based on a per share value of $21.79, the closing price of the Issuer's common stock on April 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's spouse's cash bonus earned for the fiscal year ended January 31, 2024 under the Issuer's Variable Compensation Plan. The Reporting Person's spouse elected to convert such portion of her earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted are based on a per share value of $21.79, the closing price of the Issuer's common stock on April 5, 2024."}],"balance_after":7603,"source":{"system":"sec-edgar","filing":"0001562180-24-003373","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024003373/primarydocument.xml","form_type":"4"}},{"id":1544588,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-04-09T23:37:36.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":6105,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ended January 31, 2024 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert 50% of such cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted are based on a per share value of $21.79, the closing price of the Issuer's common stock on April 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ended January 31, 2024 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert 50% of such cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted are based on a per share value of $21.79, the closing price of the Issuer's common stock on April 5, 2024."}],"balance_after":210164,"source":{"system":"sec-edgar","filing":"0001562180-24-003373","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024003373/primarydocument.xml","form_type":"4"}},{"id":1564848,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-03-21T20:11:41.000Z","date":"2024-03-20","kind":"sale","planned":false,"acquired":false,"shares":30,"price":23.6597,"value":709.791,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.28 to $24.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7095,"source":{"system":"sec-edgar","filing":"0001562180-24-002898","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024002898/primarydocument.xml","form_type":"4"}},{"id":1566031,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-03-20T20:21:23.000Z","date":"2024-03-19","kind":"sale","planned":false,"acquired":false,"shares":402,"price":23.2733,"value":9355.8666,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.16 to $2.64 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7125,"source":{"system":"sec-edgar","filing":"0001562180-24-002874","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024002874/primarydocument.xml","form_type":"4"}},{"id":1566030,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-03-20T20:21:23.000Z","date":"2024-03-18","kind":"sale","planned":false,"acquired":false,"shares":46,"price":22.2162,"value":1021.9452,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.17 to $22.235 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7527,"source":{"system":"sec-edgar","filing":"0001562180-24-002874","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024002874/primarydocument.xml","form_type":"4"}},{"id":1676468,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-01-18T21:52:53.000Z","date":"2024-01-17","kind":"sale","planned":false,"acquired":false,"shares":30659,"price":24.1216,"value":739544.1344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.70 to $24.47 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":204059,"source":{"system":"sec-edgar","filing":"0001562180-24-000531","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024000531/primarydocument.xml","form_type":"4"}},{"id":1676467,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-01-18T21:52:53.000Z","date":"2024-01-16","kind":"sale","planned":false,"acquired":false,"shares":2318,"price":24.5455,"value":56896.469,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.40 to $24.665 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":234718,"source":{"system":"sec-edgar","filing":"0001562180-24-000531","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024000531/primarydocument.xml","form_type":"4"}},{"id":1687991,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2024-01-04T22:31:52.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four substantially equal annual installments beginning on January 2, 2025."}],"balance_after":237036,"source":{"system":"sec-edgar","filing":"0001562180-24-000262","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218024000262/primarydocument.xml","form_type":"4"}},{"id":1703408,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2023-12-20T21:13:37.000Z","date":"2023-12-19","kind":"sale","planned":false,"acquired":false,"shares":25,"price":23.723,"value":593.075,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.595 to $23.84 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7573,"source":{"system":"sec-edgar","filing":"0001562180-23-008506","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218023008506/primarydocument.xml","form_type":"4"}},{"id":1703407,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2023-12-20T21:13:37.000Z","date":"2023-12-18","kind":"sale","planned":false,"acquired":false,"shares":234,"price":23.1527,"value":5417.7318,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.96 to $23.33 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7598,"source":{"system":"sec-edgar","filing":"0001562180-23-008506","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218023008506/primarydocument.xml","form_type":"4"}},{"id":1759054,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2023-10-17T22:11:56.000Z","date":"2023-10-16","kind":"sale","planned":false,"acquired":false,"shares":2078,"price":16.609,"value":34513.502,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.46 to $16.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":215036,"source":{"system":"sec-edgar","filing":"0001562180-23-007332","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218023007332/primarydocument.xml","form_type":"4"}},{"id":1776277,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":2623,"kind":"person","name":"Linetsky David","position":1,"cik":"0001776729","reported_name":"Linetsky David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Life Sciences"}}],"security":"Common Stock","published_at":"2023-09-20T20:17:52.000Z","date":"2023-09-18","kind":"sale","planned":false,"acquired":false,"shares":26,"price":19.7892,"value":514.5192,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.6848 to $19.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7832,"source":{"system":"sec-edgar","filing":"0001562180-23-006967","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1776729/000156218023006967/primarydocument.xml","form_type":"4"}}],"next_cursor":"2023-09-20T20:17:52.000000Z,1776277"}